• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Millennium Pharmaceuticals

Millennium Pharmaceuticals

  1. All
  2. 3rd Party
  3. Investing
  1. Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

    Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

  2. Global Burkitt Lymphoma Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, Arvinas, Bluebird - Research and Markets

    Global Burkitt Lymphoma Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, Arvinas, Bluebird - Research and Markets

  3. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.